Arrowhead Research | ARWR - Trade Creditors

Stock Price
76.67
Daily Change
-3.02 -3.79%
Monthly
12.78%
Yearly
388.03%
Q2 Forecast
75.13

Arrowhead Research reported $30.75M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Merck USD 3.86B 541M Mar/2026
Moderna USD 161M 156M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026